APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beta-Lactam Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Beta-Lactam Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025186 pages

Choose your research edition.

Industry ResearchBeta-Lactam Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Beta-Lactam Drugs Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Beta-Lactam Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beta-Lactam Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Beta-Lactam Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Beta-Lactam Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Beta-Lactam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beta-Lactam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beta-Lactam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Beta-Lactam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Beta-Lactam Drugs include Shionogi & Co., Ltd., Merck & Co., Inc., Eli Lilly and Company, Pfizer, Inc., GlaxoSmithKline plc and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Beta-Lactam Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beta-Lactam Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beta-Lactam Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Beta-Lactam Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Beta-Lactam Drugs Segment by Company

Shionogi & Co., Ltd.

Merck & Co., Inc.

Eli Lilly and Company

Pfizer, Inc.

GlaxoSmithKline plc

AstraZeneca plc

Beta-Lactam Drugs Segment by Type

Monobacteria

Penicillin

Carbapenem

Cephalosporins

Beta-Lactam Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Beta-Lactam Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-Lactam Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beta-Lactam Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-Lactam Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Beta-Lactam Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Beta-Lactam Drugs industry.

Chapter 3: Detailed analysis of Beta-Lactam Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Beta-Lactam Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Beta-Lactam Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Monobacteria Table 3. Key Players of Penicillin Table 4. Key Players of Carbapenem Table 3. Key Players of Cephalosporins Table 4. Global Beta-Lactam Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Online Pharmacies Table 6. Key Players of Hospital Pharmacies Table 7. Key Players of Retail Pharmacies Table 8. Global Beta-Lactam Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Beta-Lactam Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Beta-Lactam Drugs Market Share by Region (2021-2026) Table 11. Global Beta-Lactam Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Beta-Lactam Drugs Market Share by Region (2027-2032) Table 13. Beta-Lactam Drugs Industry Trends Table 14. Beta-Lactam Drugs Industry Drivers Table 15. Beta-Lactam Drugs Industry Opportunities and Challenges Table 16. Beta-Lactam Drugs Industry Restraints Table 17. Global Beta-Lactam Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Beta-Lactam Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Beta-Lactam Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Beta-Lactam Drugs Key Company Head Office and Area Served Table 21. Global Beta-Lactam Drugs Company, Product Type & Application Table 22. Global Beta-Lactam Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Beta-Lactam Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Beta-Lactam Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Beta-Lactam Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Beta-Lactam Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Beta-Lactam Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Beta-Lactam Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Beta-Lactam Drugs Revenue Market Share by Application (2027-2032) Table 35. Shionogi & Co., Ltd. Company Information Table 36. Shionogi & Co., Ltd. Business Overview Table 37. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Portfolio Table 39. Shionogi & Co., Ltd. Recent Development Table 40. Merck & Co., Inc. Company Information Table 41. Merck & Co., Inc. Business Overview Table 42. Merck & Co., Inc. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck & Co., Inc. Beta-Lactam Drugs Product Portfolio Table 44. Merck & Co., Inc. Recent Development Table 45. Eli Lilly and Company Company Information Table 46. Eli Lilly and Company Business Overview Table 47. Eli Lilly and Company Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly and Company Beta-Lactam Drugs Product Portfolio Table 49. Eli Lilly and Company Recent Development Table 50. Pfizer, Inc. Company Information Table 51. Pfizer, Inc. Business Overview Table 52. Pfizer, Inc. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer, Inc. Beta-Lactam Drugs Product Portfolio Table 54. Pfizer, Inc. Recent Development Table 55. GlaxoSmithKline plc Company Information Table 56. GlaxoSmithKline plc Business Overview Table 57. GlaxoSmithKline plc Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline plc Beta-Lactam Drugs Product Portfolio Table 59. GlaxoSmithKline plc Recent Development Table 60. AstraZeneca plc Company Information Table 61. AstraZeneca plc Business Overview Table 62. AstraZeneca plc Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AstraZeneca plc Beta-Lactam Drugs Product Portfolio Table 64. AstraZeneca plc Recent Development Table 65. North America Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 66. North America Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 67. North America Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 68. North America Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 69. North America Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America Beta-Lactam Drugs Market Size by Country (2021-2026) Table 71. North America Beta-Lactam Drugs Market Size by Country (2027-2032) Table 72. Europe Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 73. Europe Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 74. Europe Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 75. Europe Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 76. Europe Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe Beta-Lactam Drugs Market Size by Country (2021-2026) Table 78. Europe Beta-Lactam Drugs Market Size by Country (2027-2032) Table 79. China Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 80. China Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 81. China Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 82. China Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 84. Asia Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 85. Asia Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 86. Asia Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 87. Asia Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia Beta-Lactam Drugs Market Size by Country (2021-2026) Table 89. Asia Beta-Lactam Drugs Market Size by Country (2027-2032) Table 90. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Type (2021-2026) & (US$ Million) Table 91. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Type (2027-2032) & (US$ Million) Table 92. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Application (2021-2026) & (US$ Million) Table 93. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Application (2027-2032) & (US$ Million) Table 94. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2021-2026) Table 96. South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Beta-Lactam Drugs Product Image Figure 2. Global Beta-Lactam Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Beta-Lactam Drugs Market Share by Type: 2025 VS 2032 Figure 4. Monobacteria Image Figure 5. Penicillin Image Figure 6. Carbapenem Image Figure 7. Cephalosporins Image Figure 8. Global Beta-Lactam Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Beta-Lactam Drugs Market Share by Application: 2025 VS 2032 Figure 10. Online Pharmacies Image Figure 11. Hospital Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Global Beta-Lactam Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Beta-Lactam Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Beta-Lactam Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Beta-Lactam Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Beta-Lactam Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Beta-Lactam Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Beta-Lactam Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Beta-Lactam Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Beta-Lactam Drugs Market Share by Type (2021-2032) Figure 26. North America Beta-Lactam Drugs Market Share by Application (2021-2032) Figure 27. North America Beta-Lactam Drugs Market Share by Country (2021-2032) Figure 28. United States Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Beta-Lactam Drugs Market Share by Type (2021-2032) Figure 33. Europe Beta-Lactam Drugs Market Share by Application (2021-2032) Figure 34. Europe Beta-Lactam Drugs Market Share by Country (2021-2032) Figure 35. Germany Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Beta-Lactam Drugs Market Share by Type (2021-2032) Figure 43. China Beta-Lactam Drugs Market Share by Application (2021-2032) Figure 44. Asia Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Beta-Lactam Drugs Market Share by Type (2021-2032) Figure 46. Asia Beta-Lactam Drugs Market Share by Application (2021-2032) Figure 47. Asia Beta-Lactam Drugs Market Share by Country (2021-2032) Figure 48. Japan Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Beta-Lactam Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Beta-Lactam Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Beta-Lactam Drugs Market Share by Country (2021-2032) Figure 58. Brazil Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Beta-Lactam Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Monobacteria
  • Penicillin
  • Carbapenem
  • Cephalosporins
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Shionogi & Co., Ltd.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Beta-Lactam Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Monobacteria
  5. 1.2.3 Penicillin
  6. 1.2.4 Carbapenem
  7. 1.2.5 Cephalosporins
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Beta-Lactam Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Online Pharmacies
  11. 1.3.3 Hospital Pharmacies
  12. 1.3.4 Retail Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Beta-Lactam Drugs Growth Trends by Region
  15. 1.5.1 Global Beta-Lactam Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Beta-Lactam Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Beta-Lactam Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Beta-Lactam Drugs Market Dynamics
  1. 2.1 Beta-Lactam Drugs Industry Trends
  2. 2.2 Beta-Lactam Drugs Industry Drivers
  3. 2.3 Beta-Lactam Drugs Industry Opportunities and Challenges
  4. 2.4 Beta-Lactam Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Beta-Lactam Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Beta-Lactam Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Beta-Lactam Drugs Key Company Head office and Area Served
  4. 3.4 Global Beta-Lactam Drugs Company, Product Type & Application
  5. 3.5 Global Beta-Lactam Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Beta-Lactam Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Beta-Lactam Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Beta-Lactam Drugs Tier 1, Tier 2, and Tier 3
4 Beta-Lactam Drugs Market by Type
  1. 4.1 Global Beta-Lactam Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Beta-Lactam Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Beta-Lactam Drugs Market Size Share by Type (2021-2032)
5 Beta-Lactam Drugs Market by Application
  1. 5.1 Global Beta-Lactam Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Beta-Lactam Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Beta-Lactam Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Shionogi & Co., Ltd.
  2. 6.1.1 Shionogi & Co., Ltd. Company Information
  3. 6.1.2 Shionogi & Co., Ltd. Business Overview
  4. 6.1.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Product Portfolio
  6. 6.1.5 Shionogi & Co., Ltd. Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Beta-Lactam Drugs Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly and Company Beta-Lactam Drugs Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Pfizer, Inc.
  20. 6.4.1 Pfizer, Inc. Company Information
  21. 6.4.2 Pfizer, Inc. Business Overview
  22. 6.4.3 Pfizer, Inc. Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer, Inc. Beta-Lactam Drugs Product Portfolio
  24. 6.4.5 Pfizer, Inc. Recent Developments
  25. 6.5 GlaxoSmithKline plc
  26. 6.5.1 GlaxoSmithKline plc Company Information
  27. 6.5.2 GlaxoSmithKline plc Business Overview
  28. 6.5.3 GlaxoSmithKline plc Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline plc Beta-Lactam Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline plc Recent Developments
  31. 6.6 AstraZeneca plc
  32. 6.6.1 AstraZeneca plc Company Information
  33. 6.6.2 AstraZeneca plc Business Overview
  34. 6.6.3 AstraZeneca plc Beta-Lactam Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 AstraZeneca plc Beta-Lactam Drugs Product Portfolio
  36. 6.6.5 AstraZeneca plc Recent Developments
7 North America
  1. 7.1 North America Beta-Lactam Drugs Market Size (2021-2032)
  2. 7.2 North America Beta-Lactam Drugs Market Size by Type
  3. 7.2.1 North America Beta-Lactam Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Beta-Lactam Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Beta-Lactam Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Beta-Lactam Drugs Market Size by Application
  7. 7.3.1 North America Beta-Lactam Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Beta-Lactam Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Beta-Lactam Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Beta-Lactam Drugs Market Size by Country
  11. 7.4.1 North America Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Beta-Lactam Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Beta-Lactam Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Beta-Lactam Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Beta-Lactam Drugs Market Size (2021-2032)
  2. 8.2 Europe Beta-Lactam Drugs Market Size by Type
  3. 8.2.1 Europe Beta-Lactam Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Beta-Lactam Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Beta-Lactam Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Beta-Lactam Drugs Market Size by Application
  7. 8.3.1 Europe Beta-Lactam Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Beta-Lactam Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Beta-Lactam Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Beta-Lactam Drugs Market Size by Country
  11. 8.4.1 Europe Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Beta-Lactam Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Beta-Lactam Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Beta-Lactam Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Beta-Lactam Drugs Market Size (2021-2032)
  2. 9.2 China Beta-Lactam Drugs Market Size by Type
  3. 9.2.1 China Beta-Lactam Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Beta-Lactam Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Beta-Lactam Drugs Market Share by Type (2021-2032)
  6. 9.3 China Beta-Lactam Drugs Market Size by Application
  7. 9.3.1 China Beta-Lactam Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Beta-Lactam Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Beta-Lactam Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Beta-Lactam Drugs Market Size (2021-2032)
  2. 10.2 Asia Beta-Lactam Drugs Market Size by Type
  3. 10.2.1 Asia Beta-Lactam Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Beta-Lactam Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Beta-Lactam Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Beta-Lactam Drugs Market Size by Application
  7. 10.3.1 Asia Beta-Lactam Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Beta-Lactam Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Beta-Lactam Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Beta-Lactam Drugs Market Size by Country
  11. 10.4.1 Asia Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Beta-Lactam Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Beta-Lactam Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Beta-Lactam Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Beta-Lactam Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Beta-Lactam Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Beta-Lactam Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Beta-Lactam Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Beta-Lactam Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst